MEVAC Facilities and Production Lines
About us
MEVAC is equipped with state-of-the-art facilities and production lines to meet the growing demand for high-quality vaccines. Our advanced infrastructure enables us to produce a wide range of vaccines, including inactivated egg-based and tissue culture viral vaccines, live attenuated egg-based and tissue culture-based vaccines, recombinant vaccines, and bacterial vaccines.
Production Facilities:
We take pride in our four production facilities that are strategically designed to cater to different vaccine types and production methods. These facilities are equipped with cutting-edge technology and adhere to the highest quality standards.
Inactivated Egg-Based Production Lines:
We have three dedicated production lines for inactivated egg-based vaccines. These lines utilize specialized processes to produce vaccines that provide potent protection against targeted viral diseases. Our capacity in this area ensures a reliable supply of inactivated egg-based vaccines to meet market demand.
Live Attenuated Production Lines:
To meet the requirements of live attenuated vaccines, we have two dedicated production lines. These lines employ advanced techniques to develop vaccines that induce a controlled immune response while maintaining safety. The live attenuated production lines contribute to our diverse vaccine portfolio.
Tissue Culture Production Lines (Bioreactors and Mono Cell Layers):
Our two tissue culture production lines utilize both bioreactors and mono cell layers. These lines enable the production of vaccines using tissue culture techniques, ensuring high purity, efficacy, and safety. The advanced technology employed in tissue culture production enhances the quality and consistency of our vaccines.
Bacterial Vaccine Production Line:
In addition to viral vaccines, we have a specialized production line for bacterial vaccines. This line is designed to manufacture vaccines targeting bacterial diseases, using advanced processes and quality control measures to ensure efficacy and safety.
Massive Production Capacities:
Our facilities and production lines collectively enable us to achieve a massive production capacity of more than 11 billion doses per year. This substantial capacity reflects our commitment to meet the global demand for vaccines and support animal health on a large scale.
At MEVAC , we continually invest in our facilities, production lines, and technology to ensure efficient and reliable vaccine production. Our extensive capacities allow us to deliver a diverse range of vaccines to safeguard animal health and contribute to the well-being of animals worldwide.
Improving animal health for human wealth by Science & Innovation
- Providing complete solutions for Animal & Human health with the highest Quality Standards.
- Improve customer journey through efficient agile solutions.
- Inspire Human & Animal Wealth to be centre of excellence for vaccines innovation & technological services by Science.
- Caring for Employees as MEVAC’s ambassadors and our successful Partners.
T: Teamwork
I: Integrity
P: Passion
S: Sevent Leadership
S: Safety
MEVAC are committed to the Highest international Quality Standards & Accredited with the Following Certifications:
- Good Manufacturing Practice ( GMP )
- ISO 9001
- ISO 14001
- ISO 45001
- ISO 17025
- ISO 50001
|
Middle East for Vaccines (MEVAC) is the first private vaccine facility in Egypt for Research and Development, manufacturing, packing, and distribution of live and inactivated vaccines for MEVAC, and Toll for others. MEVAC management is committed to implementing all system requirements for:
which supports the achievement of the desired results of MEVAC objectives to monitor and review information on these external and internal issues. 2. Environmental Management System (EMS) ISO14001: 2015, to provide a framework for the protection of the environment to respond to environmental changes and balance the situation with social and economic needs. 3. Occupational Health & Safety Management System (OH&S) ISO 45001:2018, to provide a framework for managing the prevention of death, work-related injury, and ill health, to prevent work-related injury and ill health to workers, and to improve and provide a safe and healthy workplace for its workers and other persons under its control. 4. Good manufacturing rules and practices in accordance with Egyptian requirements and laws and European GMP Guidelines and relevant legal acts and regulations. The top management will install and ensure compliance with EU-GMP guidelines. It ensures the effectiveness of the QMS, by carrying out regular management reviews as required by EU-GMP. 5. Energy Management System (EnMS) ISO 50001:2018, to continually improve energy performance, including energy efficiency, energy use, and energy consumption, Searching for clean renewable energy, maintaining energy resources, and reduction of carbon emissions. At MEVAC we are confident that the implementation of these QHSE Integrated systems, Energy management system, and EU-GMP will have a positive impact on all manufacturing processes, individuals, and the work environment within MEVAC as well as the external environment. We are committed at MEVAC to establishing & developing various procedures to determine the external and internal issues that are relevant to its purpose and its strategic direction and that affect its ability to achieve the intended result(s) of these QHSE Integrated systems, Energy System, and Eu-GMP. We are committed at MEVAC to recording & assessed all issues including positive and negative factors or conditions for consideration, which affect our goals. We are seeking at MEVAC to understand the external context to be facilitated by considering issues arising from the legal, technological, competitive, market, cultural, social, and economic environments, whether international, national, regional, or local, which will affect our goals. We are seeking MEVAC to understand the internal context to be facilitated by considering issues related to values, culture, knowledge, and performance of the MEVAC Facility, which support achieving the desired result of MEVAC's goals. MEVAC is committed to determining: The interested parties that are relevant to the QHSE Integrated system, EnMS, and Eu-GMP. b. The requirements of these interested parties that are relevant to the QHSE Integrated systems, EnMS, c. Requirements for achieving and implementing EU GMP in accordance with Egyptian requirements and laws and European directives. we are committed at MEVAC to monitoring and reviewing information about these interested parties and their relevant requirements. MEVAC’s ability to consistently provide products and services that meet customer and applicable statutory and regulatory requirements. We are committed at MEVAC to determining the processes needed for the QHSE Integrated systems, EnMS, and EU GMP, and their application throughout our facility, to be considered:
|
|
MEVAC QHSE Integrated systems and EnMS were activated in all company sites to meet all the requirements of an international standard: ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and ISO 50001:2018 to ensure and maximize the effectiveness and efficiency of controls to prevent all types of risk as well as risk controls negative has been factored in that commitment cycle "Plan-Do-Check-Act" MEVAC’s Top management approach to the QHSE Integrated systems and EnMS supports building success over the long term and creates options for contributing to sustainable development by:
|
|
We are committed at MEVAC & continually strive to achieve all requirements of the QHSE Integrated systems and EnSM and be fulfilled without exclusion. |
a- The products are consistently produced and controlled in compliance with quality standards and appropriate for their intended use. b- Ensuring the best quality products and services to the customers. c- MEVAC is accountable to ensure procedures are in place that adequately defines the expectations for work that supports or directly affects, product quality, product registration, and/or data that support product quality and animal or human safety |
MEVAC Global Presence in more than 36 Countries - 4 Continents worldwide